Verona Pharma plc logo

VRNAVerona Pharma plc

VRNA Stock Price, Valuation & Chart | Verona Pharma plc

Compare

VRNA Historical price chart

VRNA Key Stats

Fair Value
Disclaimer

Disclaimer: This fair value estimate is for informational purposes only and should not be considered as investment advice. Fair value calculations are based on DCF (Discounted Cash Flow), P/E Multiple, and P/S Multiple models and assumptions that may not reflect actual market conditions. Always conduct your own research and consult with a financial advisor before making investment decisions.

Market Capitalization72.68B
PE Ratio-102.8
EPS-1.04
Trading Volume1.87M
Today's High/Low106.91/106.91
Dividend Yield0.00
52 Week High/Low106.93/31.09
Shares Outstanding679.83M
VRNA Financial Statement
VRNA Analyst ratings
VRNA Analysis & performance metrics

VRNA Company profile

Verona Pharma plc, a clinical stage biopharmaceutical company, focuses on development and commercialization of therapies for the treatment of respiratory diseases with unmet…

VRNA Management team

Management
Matthew Casbon
Vice President of Sales, Marketing & Training
Tara Rheault M.P.H., Ph.D.
Chief Development Officer
Christopher Martin
Chief Commercial Officer
Caroline Diaz
Chief Regulatory Officer
Mark W. HahnCFO
Chief Financial Officer
Andrew Fisher
General Counsel
Kathleen A. Rickard M.D.
Chief Medical Officer
Victoria StewartCTO
Senior Director of Investor Relations & Communications
Total 8 executives

VRNA Frequently asked questions

What is Verona Pharma plc (VRNA) Stock Price?

Current stock price of Verona Pharma plc (VRNA) stock is $106.91. The stock price is +0.11% higher in the session. The intraday range can be seen from this page. Volume of Verona Pharma plc (VRNA) stock is 1.87M.

Last updated at 07 Oct 2025, 08:00 pm.

Why is the Verona Pharma plc (VRNA) stock price going up or down today?

The stock price of Verona Pharma plc (VRNA) can change with earnings, company news, and overall market sentiment. Verona Pharma plc operates in the Healthcare / Biotechnology market, so sector-wide moves can also affect the share price. Use the live price, percentage change, and volume on this page to judge whether a move looks meaningful.

Is the Verona Pharma plc stock expensive at its current price?

Whether Verona Pharma plc looks expensive depends on valuation metrics versus its growth outlook. The P/E ratio shown for VRNA on this page is -102.80. EPS on this page is -1.04. Compare those figures with peers and growth expectations before deciding if the current Verona Pharma plc price is justified.

How has the stock price of Verona Pharma plc (VRNA) performed historically?

Historical performance for Verona Pharma plc (VRNA) is shown on the price chart on this page. Review multi-period moves alongside volume to see how VRNA reacted to past earnings and market events.

Should I buy Verona Pharma plc (VRNA) stock, at this price?

Buying Verona Pharma plc (VRNA) depends on your risk tolerance, time horizon, and portfolio needs. As a Healthcare name, weigh the live quote, key stats, and valuation links on this page rather than a single price point.